Hubei Weisen Pharmaceutical

Hubei Weisen Pharmaceutical Co., Ltd. is a specialized pharmaceutical manufacturer headquartered in Wuhan, China, established in 1992. The company is most widely recognized for its flagship gastrointestinal product, Weisen-U, which is a leading treatment for gastric and duodenal ulcers in the Chinese market. Beyond its core focus on gastroenterology, Hubei Weisen produces a variety of chemical drugs and traditional Chinese medicines targeting cardiovascular health, respiratory conditions, and metabolic disorders. The firm operates modern, GMP-certified manufacturing facilities and maintains a robust distribution network across mainland China. As a joint venture with historical ties to Hong Kong-based Kin Fung Weisen-U, the company combines regional brand heritage with large-scale industrial production capabilities.